Today in Peak History (April 21-April 30)
Release time:
2020-08-14
peak (4# March 21 - 4# July 30 )
1973 4 26 , with the approval of the higher authorities, the general branch Committee of Jinhua cement factory of the communist party of China was formally established and should be Changshan as the general branch secretary.
1991 4 May 26 , Jinhua Municipal People's Government approved the joint venture between Jianfeng Cement Group Co., Ltd. and Zhejiang Cement Products Factory, and the company was renamed "Zhejiang Jianfeng Building Materials Group Co., Ltd".
1995 4 29 , Jianfeng Group laid the foundation for the Hope Primary School donated and built by Naqu District in Tibet, such as Xiaquka Township. This is the first Hope Primary School donated by Jianfeng, and it is also the first Hope Primary School donated by an enterprise in Tibet. Song Ping, former member of the Standing Committee of the Political Bureau of the CPC Central Committee, inscribed the name of "Zhejiang Jianfeng Hope Primary School. Fu Deqing, then general manager of Jianfeng Group, Yin Rongfu, deputy secretary of the party committee, and others went to Tibet to attend the groundbreaking ceremony.
2011 4 In late March, the first session of the sixth session of the Jinhua Municipal People's Congress and the first session of the sixth session of the Chinese People's Political Consultative Conference were held. Chairman Jiang Xiaomeng and General Manager Yu Jianhong of the Group Company participated in the "two sessions" of the city respectively. Jiang Xiaomeng was elected as a member of the Standing Committee of the sixth National People's Congress.
2016 4 29 , Tianjin Jianfeng Natural Products Company successfully passed the official certification audit of the US Food and Drug Administration (FDA ) with zero defects and zero improvement results.
2017 4 January 24 , Jinhua Red Cross announced the recognition of 2016 Red Cross Humanitarian Promotion Award advanced units and individuals, and Jianfeng Pharmaceutical Company won the Red Cross Humanitarian Promotion Award advanced collective.
2017 4 February 27 , at the first "Ba Wu Craftsman" naming conference in Jinhua City, Wu Guangjun, electrical director of Jinxi Factory of Jianfeng Pharmaceutical Company, was awarded the title of "Ba Wu Craftsman. (Xu Xia finishing)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page